Table 2.
Response to immunotherapy based on the prediction model
| Survival prediction | Low | High | χ2 | P |
|---|---|---|---|---|
| For training cohort (n = 130) | n = 101 | n = 29 | ||
| Best overall response-no. (%) | 12.134 | 0.002 | ||
| Partial response (PR) | 33 (32.7) | 5 (17.2) | ||
| Stable disease (SD) | 57 (56.4) | 13 (44.8) | ||
| Progressive disease (PD) | 11 (10.9) | 11 (37.9) | ||
| For validation cohort (n = 63) | n = 46 | n = 17 | ||
| Best overall response-no. (%) | 7.603 | 0.022 | ||
| Partial response (PR) | 15 (32.6) | 2 (11.8) | ||
| Stable disease (SD) | 27 (58.7) | 9 (52.9) | ||
| Progressive disease (PD) | 4 (8.7) | 6 (35.3) |